PKC-θ is a Drug Target for Prevention of T Cell-Mediated Autoimmunity and Allograft Rejection

E-ISSN： 2212-3873|10|4|367-372

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.10, Iss.4, 2010-12, pp. : 367-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein Kinase C-&thgr; (PKC&thgr;), a Potential Drug Target for Therapeutic Intervention with Human T Cell Leukemias

Current Cancer Drug Targets, Vol. 2, Iss. 2, 2002-06 ,pp. : 125-134

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic cell-mediated viral transmission: a potential drug target?

By de Witte Lot van Kooyk Yvette Geijtenbeek Teunis BH

Future Virology, Vol. 1, Iss. 5, 2006-09 ,pp. : 615-622

Future Medicine

Access to resources Recommend Favorite

Are B Cells a Potential Target for Therapeutic Intervention in the Classical T Cell-Mediated Autoimmune Disease Type 1 Diabetes?

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 2, 2009-06 ,pp. : 130-138

Bentham Science Publishers

Access to resources Recommend Favorite

Immune-adhesion molecules in the prevention of allograft rejection and reperfusion injury

By Behrend M.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 789-805

Informa Healthcare

Access to resources Recommend Favorite

EBV, autoimmunity and dual T-cell receptors

By Niller Hans Helmut Minarovits Janos

Future Virology, Vol. 7, Iss. 3, 2012-03 ,pp. : 217-220

Future Medicine

Access to resources Recommend Favorite